Blink index as a response predictor of blepharospasm to botulinum neurotoxin-A treatment

被引:9
|
作者
Jang, Jeongkyeong [1 ]
Lew, Helen [1 ]
机构
[1] CHA Univ, Dept Ophthalmol, Coll Med, CHA Bundang Med Ctr, 59 Yatap Ro, Seongnam 13496, South Korea
来源
BRAIN AND BEHAVIOR | 2021年 / 11卷 / 11期
关键词
blepharospasm; blink index; blink profile; botulinum neurotoxin-A; HEMIFACIAL SPASM; TOXIN;
D O I
10.1002/brb3.2374
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Purpose We investigated the blink profiles and blink index using ocular surface interferometer in the patients with blepharospasm (BSP) and identified points to consider predictive factor after BSP treatment. Methods In total, 117 eyelids of 59 elderly patients and 20 eyelids of 10 age-matched control group were studied. All BSP patients applied botulinum toxin-A (BoNT-A) injection for treatment of BSP. An ocular surface interferometer (LipiView; TearScience, Morrisville, NC, USA) was used to measure blink profile and blink index; total and incomplete blinks/20 s, and the partial blink ratio (PBR). Eyelid blink time (including lid closing time, closure time, lid opening time), interblink times (IBT), closing speeds (OS), and opening speeds (OS) were analyzed using 600 blinks recorded over 20 s. Results Total blink rate was significantly higher in BSP patients compared to the age-matched control group (p = .029) but other time-related and speed-related index including interpalpebral fissure, PBR, blink time, closure time (CT), interblink time, CS, and OS were not significantly different. In the responder of BSP patients, the average age was higher, CT was shorter, CS was faster than nonresponder (age; p = .016, CT; p < .001, CS; p = .042). Conclusion The blink index by analyzing the blink profile using ocular surface interferometer, and this blink index may be used as a predictive factor for evaluating the clinical response after BoNT-A injection in blepharospasm patients.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Intraoperative findings of abnormal muscle response for hemifacial spasm following botulinum neurotoxin treatment
    Yoko Nakayama
    Tadashi Kawaguchi
    Masafumi Fukuda
    Makoto Oishi
    Acta Neurochirurgica, 2021, 163 : 3303 - 3309
  • [42] Effect of Botulinum Toxin A Treatment on Eyelid Pressure in Eyes with Blepharospasm
    Namiguchi, Koji
    Mizoue, Shiro
    Ohta, Kiyohiko
    Shiraishi, Atsushi
    CURRENT EYE RESEARCH, 2018, 43 (07) : 896 - 901
  • [43] Intrastriatally injected botulinum neurotoxin-A differently effects cholinergic and dopaminergic fibers in C57BL/6 mice
    Hawlitschka, Alexander
    Holzmann, Carsten
    Witt, Sarah
    Spiewok, Juliane
    Neumann, Anne-Marie
    Schmitt, Oliver
    Wree, Andreas
    Antipova, Veronica
    BRAIN RESEARCH, 2017, 1676 : 46 - 56
  • [44] Botulinum toxin a in the treatment of blepharospasm -: A 10-year experience
    Silveira-Moriyama, L
    Gonçalves, LR
    Chien, HF
    Barbosa, ER
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2005, 63 (2A) : 221 - 224
  • [45] Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm
    Bettina Wabbels
    Wolfgang H. Jost
    Peter Roggenkämper
    Journal of Neural Transmission, 2011, 118 : 925 - 943
  • [46] A Review of Tolerance and Safety Profiles of Long-Term Botulinum Neurotoxin Type A in Asian Patients with Hemifacial Spasm and Benign Essential Blepharospasm
    Lai, Kenneth K. A. Hei
    Tsang, Alan
    Kuk, Andrew K. T.
    Ko, Callie K. L.
    Chan, Edwin
    Ko, Simon T. C.
    NEURO-OPHTHALMOLOGY, 2021, 45 (05) : 293 - 300
  • [47] Clinical and psychological factors influencing botulinum toxin efficacy in the treatment of hemifacial spasm and blepharospasm
    Burbaud, P
    Arnaud, A
    Burbaud, A
    Lagueny, A
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 1995, 18 (12): : 751 - 757
  • [48] Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm
    Cannon, Paul S.
    MacKenzie, Kenneth R.
    Cook, Anne E.
    Leatherbarrow, Brian
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 38 (07) : 688 - 691
  • [49] The combined treatment with orbital and pretarsal botulinum toxin injections in the management of poorly responsive blepharospasm
    Esposito, Marcello
    Fasano, A.
    Crisci, C.
    Dubbioso, R.
    Iodice, R.
    Santoro, Lucio
    NEUROLOGICAL SCIENCES, 2014, 35 (03) : 397 - 400
  • [50] Do randomised controlled trials evaluating functional outcomes following botulinum neurotoxin-A align with focal spasticity guidelines? A systematic review
    Sutherland, Edwina
    Hill, Bridget
    Singer, Barby J.
    Ashford, Stephen
    Hoare, Brian
    Hastings-Ison, Tandy
    Fheodoroff, Klemens
    Berwick, Steffen
    Dobson, Fiona
    Williams, Gavin
    DISABILITY AND REHABILITATION, 2022, 44 (26) : 8515 - 8523